Wara Samar
14th April 2025
Valeo Health Closes $12M Series B Round, Eyes GCC and Beyond
UAE-based Valeo Health, a pioneer in AI-driven personalised healthcare, has announced the successful close of its $12 million Series B funding round. This brings the company’s total funding to $20 million, marking a major step forward in its mission to make science-backed, data-led healthcare more accessible across the Gulf Cooperation Council (GCC) region.
The round was led by Flintera, with participation from existing backers Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital, along with new investors including Oraseya and Eirad.
Fueling Regional Growth Through Personalised Care
Founded by Sundeep Sahni, Nadine Karadag, and Ankur Majumder, Valeo Health has built a reputation for its proprietary Longevity technology, personalised treatment plans, and delivery of healthcare at home. The company aims to use the new capital to expand its reach within KSA, the UAE, and across the broader GCC while continuing to scale its AI-powered solutions.
“We are thrilled by the strong investor support as we continue to redefine how people engage with their health,” said Sundeep Sahni, CEO and Co-Founder of Valeo Health in a statement. “This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, ensuring more individuals benefit from proactive healthcare solutions.”
Co-founder Nadine Karadag echoed the sentiment: “This investment validates our team’s hard work and strengthens our ability to scale personalised healthcare across the region.”
Valeo Health was recently selected for the Google for Startups Growth Academy: AI for Health, a global program supporting the most promising healthtech innovators, further validating its technological capabilities and global relevance. As a trusted name in the region’s healthtech space, Valeo continues to empower individuals with real-time insights and customised wellness pathways, cementing its position at the forefront of personalised care.
MedTech World, which convenes top voices in health innovation, previously spotlighted the importance of personalised care at its Dubai 2025 event, during a focused session titled ‘Unlocking Longevity: A Holistic Approach to Genomics, Lifestyle, Wellness, and Precision Health.’ This session underscored the growing momentum behind integrating genomics, AI, and lifestyle medicine into mainstream healthcare, a shift that is increasingly being reflected across the healthtech sector. From patient-centric platforms and at-home diagnostics to longevity-focused startups and wellness ecosystems, the demand for tailored, data-informed healthcare solutions is driving new models of delivery and engagement across the region and beyond.
Missed MedTech World Dubai?
You can still catch the momentum. Book your ticket for MedTech Malta 2025, happening from 12 to 14 November in Valletta, at the best rate yet. Whether you’re fundraising, exploring partnerships, or showcasing your solution, this is the place to do it. Opportunities are still open for speakers, sponsors, and pitch competition participants. Reach out at [email protected] to get involved.
